Cerebrospinal fluid markers of alzheimer’s pathology relate to aMCI among people with HIV

Key Points

• Cerebrospinal fluid markers are linked to aMCI in a portion of the HIV population, indicating a significant finding.
• Beta-amyloid and tau protein levels presented critical correlations, enhancing our understanding of Alzheimer's disease mechanisms.
• Observational analysis focused on the interplay of cerebrospinal fluid markers, aMCI, and HIV, highlighting important biological connections.
• This suggests a potential for early intervention based on cerebrospinal fluid biomarkers, though more research is needed for broader applicability.